KATHLEEN HUDSON: Open Payments
NPI 1881118420 · MILLVILLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,948 in 111 payments from 20 companies in 2025. Trend: 2023 $2,018 · 2024 $1,862 · 2025 $2,948
Food & beverage: $2,948
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 18 | $561 |
| Madrigal Pharmaceuticals | 15 | $517 |
| ABBVIE INC. | 22 | $421 |
| Janssen Biotech, Inc. | 10 | $394 |
| Janssen Scientific Affairs, LLC | 2 | $188 |
| Ardelyx, Inc. | 11 | $172 |
| Regeneron Healthcare Solutions, Inc. | 8 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $158 |
| Phathom Pharmaceuticals, Inc. | 5 | $67 |
| Gilead Sciences, Inc. | 2 | $47 |
Products named: TREMFYA, Sucraid, REZDIFFRA, DUPIXENT, IBSRELA, XIFAXAN, LINZESS, VOQUEZNA.
Industry payments across DE — which companies pay providers there.
